ABVC BioPharma, Inc.
ABVC BioPharma, Inc. scores highest on Anchor (57) and lowest on Price (25). Its PosiPenta is 38.47 out of 100, weaker than most similar companies.
On the Penta Grid this week, ABVC BioPharma, Inc. is Grid #590 of 837 in the Healthcare sector in United States, and Grid #3,027 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| ABVC BioPharma, Inc. | 38.47 | 25 | 40 | 31 | 39 | 57 |
| Milestone Scientific Inc. | 39.72 | 8 | 52 | 57 | 34 | 48 |
| CEL-SCI Corporation | 26.87 | 22 | 20 | 27 | 18 | 47 |
| Rockwell Medical, Inc. | 50.57 | 41 | 62 | 58 | 51 | 41 |
| OneMedNet Corporation | 41.02 | 0 | 38 | 21 | 93 | 53 |
| Atossa Therapeutics, Inc. | 37.28 | 38 | 28 | 27 | 60 | 34 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -3.06 |
| P/B ratio | 2.38 |
EEarnings
| Trailing EPS | ₹-28.41 |
| Forward EPS | ₹-41.67 |
NNitro
| Price | 86.94 |
| 52-week high | 290.77 |
| 52-week low | 66.96 |
| Fall from 52-week high | 70.1% |
TTorque
| Return on equity (ROE) | -69.86% |
| Debt-to-equity | 0.24 |
AAnchor
| Beta (price swings) | 0.51 |
| Market cap | ₹232 Cr |
| Insider holding | 18.09% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is ABVC BioPharma, Inc.'s PosiPenta score?
ABVC BioPharma, Inc.'s PosiPenta is 38.47 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does ABVC BioPharma, Inc. stand on the Penta Grid?
On the Penta Grid this week, ABVC BioPharma, Inc. is Grid #590 of 837 in the Healthcare sector in United States, and Grid #3,027 of 4,000 in United States.
Which PosiPenta pillar is strongest for ABVC BioPharma, Inc.?
Anchor (stability and dividends), with a score of 57 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for ABVC BioPharma, Inc.?
Price (valuation), with a score of 25 out of 100: weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.